An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene -: the first case of transplanted CML with micro bcr

被引：11
|
作者：
Polák, J
Koza, V
Cetkovsky, P
Haskovec, C
机构：
[1] Inst Hematol & Blood Transfus, Dept Mol Genet, CR-12820 Prague 2, Czech Republic
[2] Fac Hosp, Dept Hematooncol, Plzen, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2000年 / 25卷 / 10期
关键词：
D O I：
10.1038/sj.bmt.1702412
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1109 / 1110
页数：2
相关论文
共 50 条
  • [21] Successful treatment using omacetaxine for a patient with CML and BCR-ABL2 35INS
    Mahadeo, Kris M.
    Cole, Peter D.
    BLOOD, 2010, 115 (18) : 3852 - 3852
  • [22] DETECTION OF BCR-ABL GENE REARRANGEMENT BY FISH IN A PH-NEGATIVE CML PATIENT WITH A COMPLEX KARYOTYPE
    NEMANA, L
    BEHZADI, N
    HABIBIAN, R
    HAJIANPOUR, AK
    HAJIANPOUR, MJ
    CYTOGENETICS AND CELL GENETICS, 1995, 71 (04): : 397 - 398
  • [23] CML with E8A2 BCR-ABL fusion: The fourth breakpoint cluster region?
    Demehri, S
    Lange, T
    Paschka, P
    Branford, S
    Koizumi, T
    Sugimoto, T
    Lim, LC
    Schultheis, B
    Kegel, T
    Martinelli, G
    Hochhaus, A
    Druker, BJ
    Deininger, MW
    BLOOD, 2004, 104 (11) : 291A - 291A
  • [24] Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML
    Dupont, M
    Jourdan, E
    Chiesa, J
    LEUKEMIA, 2000, 14 (11) : 2011 - 2012
  • [25] Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML
    M Dupont
    E Jourdan
    J Chiesa
    Leukemia, 2000, 14 : 2011 - 2012
  • [26] An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation
    Torres, Fatima
    Ivanova-Dragoeva, Anna
    Pereira, Monica
    Veiga, Joana
    Rodrigues, Antonio S.
    Sousa, Aida Botelho
    Tavares, Purificacao
    Fernandes, Alexandra R.
    LEUKEMIA & LYMPHOMA, 2007, 48 (05) : 1034 - 1037
  • [27] Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report
    Manzella, Livia
    Tirro, Elena
    Vitale, Silvia Rita
    Puma, Adriana
    Consoli, Maria Letizia
    Tambe, Loredana
    Pennisi, Maria Stella
    Di Gregorio, Sandra
    Romano, Chiara
    Tomarchio, Cristina
    Di Raimondo, Francesco
    Stagno, Fabio
    IN VIVO, 2020, 34 (03): : 1481 - 1486
  • [28] A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript
    Li, Xiaoqing
    Yang, Jing
    Chen, Xiangjun
    Liu, Jun
    Li, Hongrui
    Zheng, Jine
    He, Yanli
    Chen, Zhong
    Huang, Shiang
    CANCER GENETICS AND CYTOGENETICS, 2007, 176 (02) : 166 - 168
  • [29] Variant e19a2 BCR-ABL1 Fusion Transcript in Typical Chronic Myeloid Leukemia
    Tutulan-Cunita, Andreea Cristina
    Chirieac, Sorina Mihaela
    Mocanu, Gabriela
    Luca, Catalina
    Costache, Marieta
    Lungeanu, Agripina
    Arghir, Aurora
    CLINICAL LABORATORY, 2011, 57 (9-10) : 785 - 788
  • [30] The kinetics of BCR-ABL transcript levels in CML patients in chronic or accelerated phase during imatinib mesylate treatment.
    Klamova, H
    Moravcova, J
    Zmekova, V
    Voglova, J
    Faber, E
    BLOOD, 2003, 102 (11) : 325B - 326B
12345